Â鶹app

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Â鶹app - Outstanding Awards (Details)

v3.24.3
Stock-Based Compensation - Â鶹app - Outstanding Awards (Details)
$ / shares in Units, shares in Thousands, $ in Millions
9 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Additional disclosures Ìý
Total unrecognized compensation cost related to unvested equity awards | $ $ 15
Weighted average period of recognition related to unvested equity awards (in years) 2 years 1 month 6 days
Formula One Group | Common Class A Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Formula One Group | Common Class B Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Formula One Group | Common Class C Ìý
Number of options Ìý
Outstanding at beginning of period 6,599
Granted 87
Exercised (1,904)
Outstanding at end of period 4,782
Exercisable at end of period 3,904
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 37.62
Granted | $ / shares 72.53
Exercised | $ / shares 34.13
Outstanding at end of period | $ / shares 39.64
Exercisable at end of period | $ / shares $ 37.37
Additional disclosures Ìý
Weighted average remaining life, outstanding 2 years 8 months 12 days
Weighted average remaining life, exercisable 2 years 4 months 24 days
Aggregate intrinsic value, outstanding | $ $ 181
Aggregate intrinsic value, exercisable | $ $ 156
Common stock reserved for issuance 4,800
Â鶹app Live Group | Common Class A Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Â鶹app Live Group | Common Class B Ìý
Number of options Ìý
Granted 0
Outstanding at end of period 0
Â鶹app Live Group | Common Class C Ìý
Number of options Ìý
Outstanding at beginning of period 1,652
Granted 71
Exercised (264)
Forfeited/Cancelled (10)
Outstanding at end of period 1,449
Exercisable at end of period 1,085
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 42.36
Granted | $ / shares 40.00
Exercised | $ / shares 38.95
Forfeited/Cancelled | $ / shares 42.29
Outstanding at end of period | $ / shares 42.86
Exercisable at end of period | $ / shares $ 43.77
Additional disclosures Ìý
Weighted average remaining life, outstanding 3 years
Weighted average remaining life, exercisable 2 years 4 months 24 days
Aggregate intrinsic value, outstanding | $ $ 12
Aggregate intrinsic value, exercisable | $ $ 8
Common stock reserved for issuance 1,400